Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Amneal Pharmaceuticals, Inc. (AMRX) Insider Trading

4 open-market trades reported since Aug 13, 2026: 0 purchases worth $0 and 4 sales worth $7.22M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
John KielyDirector0$01$882KAug 14, 2026
Jason B. DalyGeneral Counsel0$02$3.77MAug 13, 2026
Nikita ShahPresident0$01$2.56MAug 13, 2026

All trades

AMRX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Aug 14Aug 13John KielyDirectorDirector▼ SELL50,00017.64$882K−19%Form 4 ↗
Aug 13Aug 12Jason B. DalyGeneral CounselGeneral Counsel▼ SELL210,00017.40$3.65M−86%Form 4 ↗
Aug 13Aug 12Nikita ShahPresidentPresident▼ SELL146,40317.51$2.56M−37%Form 4 ↗
Aug 13Aug 11Jason B. DalyGeneral CounselGeneral Counsel▼ SELL6,61317.70$117K−2.6%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings